Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.

CONCLUSIONS: There proved to be no apparent superiority of PEM in predicting pCR at the interim time point. Positron emission mammography had greater diagnostic capability for detecting residual cancer after all courses of NAC. PMID: 28072617 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28072617?dopt=Abstract

Source: Clinical Genitourinary Cancer - January 8, 2017 Category: Cancer & Oncology Authors: Noritake M, Narui K, Kaneta T, Sugae S, Sakamaki K, Inoue T, Ishikawa T Tags: Clin Nucl Med Source Type: research